Our research group focus on most common bleeding disorder in the world - von Willebrand disease, especially in women. The prevalence of vWD is as high as 1% across the world.
Despite the fact that men and women are equally affected, females usually meet specific hemostatic challenges during menstruation and childbirth.
Many clinicians note lack of guidelines on clinical management of VWD in Ob&Gyn.
We aim to elucidate hidden fundamental mechanisms underlying VWD and thus improve human health.